Boston Scientific Corp.’s iCross coronary imaging catheter hit the United States market March 19, two days after the company said two of its new drug coated stents should debut in Europe later this year — possibly earlier in non-EU countries.
The Natick medical device colossus said its iCross coronary imaging catheter, designed for use with its intravascular ultrasound iLab imaging system, is now available in the U.S.
Two days earlier, CEO Jim Tobin told analysts at an investor’s conference that BSC’s Taxus Element and Promus Element stents are set to appear in Europe late this year.
The Element is slated for European launch in October and the Promus is on track for a November launch, and could be introduced in non-EU countries such as Singapore next month, Tobin said.